Orphanet: Pesquisa simples
x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

208 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

AUSTRIA

NIEDERÖSTERREICH
ST. PÖLTEN

Ensaio a decorrerLAHENE Study: Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy (phase 2)
Universitätsklinikum St. Pölten
Karl Landsteiner Institut für klinische Neurologie und Neuropsychologie

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
VILLEJUIF

Ensaio em fase de recrutamentoEnsaio a decorrerBIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Bayern
REGENSBURG

ALEMANHA

Bayern
REGENSBURG

Ensaio em fase de recrutamentoEnsaio a decorrerINFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

ALEMANHA

Bayern
REGENSBURG

Ensaio a decorrerNOA-07: Multicentre pilot study for the therapy of Medulloblastoma of the adulthood (Phase II)
medbo Bezirksklinikum Regensburg
Klinik und Poliklinik für Neurologie der Universität Regensburg

ALEMANHA

Niedersachsen
GÖTTINGEN

ALEMANHA

Nordrhein-Westfalen
ESSEN

Ensaio em fase de recrutamentoEnsaio a decorrerINFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

AUSTRIA

OBERÖSTERREICH
LINZ

Ensaio em fase de recrutamentoEnsaio a decorrerMEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Kepler Universitätsklinikum - Med Campus IV.
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

SALZBURG
SALZBURG

Ensaio em fase de recrutamentoEnsaio a decorrerMEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

STEIERMARK
GRAZ

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerMEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ensaio a decorrerSTEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

FRANCA

AUVERGNE-RHONE-ALPES
GRENOBLE

FRANCA

NOUVELLE AQUITAINE
BORDEAUX

Ensaio em fase de recrutamentoEnsaio a decorrerTazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study (Phase II) - FR
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes

POLONIA

Warszawa
WARSAW

Ensaio em fase de recrutamentoEnsaio a decorrerCooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PL
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD

PORTUGAL

NORTE
PORTO

Ensaio em fase de recrutamentoEnsaio a decorrerCooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PT
Centro Hospitalar de S. João, EPE
Unidade de Hematologia e Oncologia Pediátrica

REINO UNIDO

West Yorkshire
LEEDS

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Mecklenburg-Vorpommern
GREIFSWALD

ALEMANHA

Nordrhein-Westfalen
KÖLN

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerVINILO: Phase I-II Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults With Refractory or Recurrent Low-Grade Glioma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerHigh Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Ensaio em fase de recrutamentoEnsaio a decorrerLINES: European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ESPANHA

Comunidad Valenciana
VALENCIA

Ensaio em fase de recrutamentoEnsaio a decorrerEuropean Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación clínica y traslacional en cáncer

ESPANHA

Comunidad Valenciana
VALENCIA

Ensaio em fase de recrutamentoEnsaio a decorrerBEACON-Neuroblastoma Trial: A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación clínica y traslacional en cáncer

ESTADOS UNIDOS

California
LA JOLLA

Ensaio a decorrerFinanciado por um membro do IRDiRCA Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas - US
University of California San Diego
University of California, San Diego

FRANCA

ILE-DE-FRANCE
VILLEJUIF

IRLANDA

County Dublin
DUBLIN

Ensaio a decorrerA randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - BEACON-Neuroblastoma Trial - IE
Children's Health Ireland @ Crumlin
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRLANDA

County Dublin
DUBLIN

Ensaio em fase de recrutamentoEnsaio a decorrerSIOP Ependymoma II : An International Clinical Program for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Ependymoma (Phase II-III) - IE
Children's Health Ireland @ Crumlin
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

ITALIA

LOMBARDIA
MILANO

Ensaio a decorrerSecond italian protocol of diagnosis and treatment of childhood ependymoma
Fondazione IRCCS Istituto Nazionale dei Tumori
Unità di Neuro-Oncologia Pediatrica

ITALIA

LOMBARDIA
MILANO

Ensaio em fase de recrutamentoEnsaio a decorrerPhase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
UOC Neurochirurgia 2 - Neurochirurgia Vascolare

REINO UNIDO

Greater London
LONDON

REINO UNIDO

Greater London
LONDON

Ensaio em fase de recrutamentoEnsaio a decorrerNB 2002 06: High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - UK
University College London Hospitals, NHS Foundation Trust
The Somers Clinical Research Facility Level 1

REINO UNIDO

West Midlands
BIRMINGHAM

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

Ensaio a decorrerGERAS: Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation in Elderly Patients With Glioblastoma
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie

ALEMANHA

Baden-Württemberg
TÜBINGEN

ALEMANHA

Bayern
MÜNCHEN

Ensaio em fase de recrutamentoEnsaio a decorrerGlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

ALEMANHA

Berlin
BERLIN

Ensaio em fase de recrutamentoEnsaio a decorrerThe C-GBM Study: Prospective controlled phase II trial of Cabazitaxel in patients with Temozolomide refractory Glioblastoma Multiforme - DE
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

ALEMANHA

Hamburg
HAMBURG

Ensaio a decorrerPhase 3b Study for Management of Ocular Side Effects in Subjects With EGFR-amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414) -DE-
Hubertus Wald Tumorzentrum/ Universitäres Cancer Center (UCCH)
Comprehensive Cancer Center (CCC) Hamburg

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

Ensaio a decorrerPharmacokinetics of temozolomide in cerebrospinal fluid in children with malignant brain tumors (phase 1)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCA

AUVERGNE-RHONE-ALPES
BRON

Ensaio em fase de recrutamentoEnsaio a decorrerRandomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Service de neurochirurgie tumorale - chirurgie des malformations vasculaires du systéme nerveux

FRANCA

ILE-DE-FRANCE
BOBIGNY

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerA Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerONCOVIRAC : Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (Phase I-II)
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCA

OCCITANIE
TOULOUSE

FRANCA

PROVENCE-ALPES-COTE D'AZUR
NICE

PAISES BAIXOS

Limburg
MAASTRICHT

PAISES BAIXOS

Noord-Holland
AMSTERDAM

PAISES BAIXOS

Zuid-Holland
ROTTERDAM

REINO UNIDO

Greater London
LONDON

SUICA

Suisse Alémanique
BERN

Ensaio a decorrerRESDEX - Restrictive Use of Dexamethasone in Glioblastoma
University Hospital Inselspital
Universitätsklinik für Neurochirurgie

Ensaio (s) clínico (s) multinacional (ais)

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

REINO UNIDO

Leicestershire
LEICESTER

CNS 2004 03: Cooperative Multicentre Study For Children And Adolescents With Low Grade Glioma (Phase III) (coordination)
Leicester Univ. Hosp. NHS - Leicester Royal Infirmary
University Hospitals of Leicester NHS Trust Headquarters

ALEMANHA

Baden-Württemberg
TÜBINGEN

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Financiado por um membro do IRDiRCIWOT: IDH mutated 1p/19q intact lower grade glioma following resection: Wait Or Treat? - A phase III study
EORTC
European Organisation for the Research and Treatment of Cancer